🏭 Manufactured by: Atradius Pharmaceuticals Pvt. Ltd.
🔍 Scan QR code for instant product information

Cefadus-CV Dry Syrup

Cefpodoxime Proxetil & Potassium Clavulanate Oral Suspension

Product Overview:
Cefadus-CV is a pediatric dry syrup combining Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic, and Potassium Clavulanate, a β-lactamase inhibitor. This formulation provides broad-spectrum antibacterial activity, even against resistant pathogens, ensuring faster and more effective treatment for common pediatric infections.

Composition (per 5ml after reconstitution):

  • Cefpodoxime Proxetil I.P. equivalent to Cefpodoxime 50mg
  • Clavulanic Acid (as Potassium Clavulanate) 31.25mg

Therapeutic Indications:

  • Cefadus-CV is indicated in pediatric patients for the treatment of:Upper and lower respiratory tract infections
  • Acute otitis media
  • Skin and soft tissue infections
  • Urinary tract infections
  • Tonsillitis and pharyngitis

Dosage & Administration:

  • Administer as per physician’s guidance based on the child’s weight and infection severity.
  • Reconstitute with freshly boiled and cooled water to the marked level.
  • Shake well before each use.
  • Use within 7 days of reconstitution and store in a refrigerator.

Key Features & Benefits:

  • Combats resistant bacterial strains effectively
  • Dual-action formula for enhanced efficacy
  • Pleasant taste suited for children
  • Trusted pediatric formulation

Packaging Information:

  • 30ml bottle of dry syrup
    Measuring cap included
    Packed in a sturdy carton box with child-friendly graphics

Storage Conditions:

  • Store in a cool, dry place away from direct sunlight.
  • After reconstitution, refrigerate between 2°C – 8°C.
  • Keep out of reach of children.

Precautions & Warnings:

  • Strictly for pediatric use only.
  • To be used under medical supervision.
  • Complete the full prescribed course to prevent bacterial resistance.
  • Not suitable for children with known allergy to cephalosporins or clavulanic acid.